Menotropins contains follicle stimulating hormone (FSH) and luteinizing hormone (LH) purified from the urine of postmenopausal women. It is used as a fertility medication that is injected either subcutaneously or intramuscularly. It is composed of LH with 2 subunits, alpha = 92 residues, beta = 121 residues and FSH with 2 subunits, alpha = 92 residues, beta=111 residues.
For the treatment of female infertility
Centre for Reproductive Medicine, Brussels, Belgium
School of Medicine & Pharmacology,University of Western Australia, Perth, Western Australia, Australia
Leuven University Fertility Center, Leuven, Vlaams Brabant, Belgium
Zekai Tahir Burak women's research and Training Hospital, Ankara, Turkey
Investigational site, Valladolid, Spain
The fertility clinic, Braedstrup, Denmark
Investigational site, Valladolid, Spain
Fertility clinic at Hvidovre Hospital, Hvidovre, Copenhagen, Denmark
Midland Fertility Services, Aldridge, West Midlands, United Kingdom
Odense Universitetshospital, Odense, Odensee C, Denmark
IVF Zentrum, Saar, Germany
Endokrinologikum Ulm, Ulm, Germany
Fertility Center Berlin, Berlin, Germany
Ovo Fertilité, Montreal, Quebec, Canada
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.